Materialise is a leading, Belgium-based provider of additive manufacturing, medical software and sophisticated 3D printing services founded in 1990.
Materialise’s proprietary software platforms, which enable and enhance the functionality of 3D printers and 3D printing operations, have become a market standard for professional 3D printing.
The Company’s markets offer ample growth opportunities including (i) increased demand for highly performing industrial 3D printers, (ii) closer relationships with customers and OEMs, (iii) expansion of distribution channels in the various sub-segments of the Materialise Medical segment and (iv) a growing requirement for patient-specific devices.
After acquiring ACTech in October 2017, a full-service manufacturer of complex metal parts, thereby reinforcing Materialise’s ability to offer complete manufacturing solutions for unique 3D-printed metal parts, the Company has concluded a partnership with BASF, the largest chemical producer in the world, on July 18 2018.
The partnership has led to an investment of USD25 million in Materialise from BASF, allowing the two partners to work together within the framework of an open business model. This will permit them to continuously improve materials and software for various 3D printing technologies and bring them more rapidly to the market. The investment took place immediately prior to the current offering.
Bryan, Garnier & Co, Piper Jaffray and KeyBanc acted as Joint Bookrunners on this oversubscribed offering. KBC acted as Co-Manager.
Materialise raised USD45 million (including a 15% greenshoe option) in a global SEC-registered equity offering targeting institutional investors across the US and Europe.
The offering priced, following a 3-day fully-marketed bookbuilding process, during which the stock rose approximately 5.3%, at USD13.00 per share, representing a premium of 3.3% to the pre-deal announcement closing share price on July 18, 2018 and a discount of 2% to the closing share price July 23, 2018.
In advance of the Offering, Materialise met with more than 20 investors in Europe (generalists and specialists) in NDR activity led by Bryan, Garnier & Co in June.
This transaction marks for Bryan, Garnier & Co the firm’s 10th equity capital market transaction 2018 YTD.
This is another landmark transaction for Bryan, Garnier & Co’s Smart Industries/PLM practice, following transactions on Metrologic, Autoform or Missler Software.
Materialise incorporates over 27 years of 3D printing experience into a range of software solutions and 3D printing services, which together form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines the largest group of software developers in the industry with one of the largest 3D printing facilities in the world.
About Bryan, Garnier & Co
Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Media & Telecoms, Healthcare, Smart Industries & Energy, Consumer, Brands & Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Zurich and New York. The firm is a member of the London Stock Exchange and Euronext.
T: +33 1 56 68 75 35
Managing Director, TMT
T: +33 1 70 36 57 21
Managing Director, ECM
T: +33 1 56 68 75 17
T: +33 1 70 36 57 43
Vice President, ECM
T: +33 1 56 68 75 28